Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianna De Francesco

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|August 24, 2019
Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine)Ernestina Marianna De Francesco, Béla Ózsvári, Federica Sotgia, et al.
Trends in Endocrinology and Metabolism: TEM|June 12, 2022
IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axisVeronica Vella, Ernestina Marianna De Francesco, Eduardo Bonavita, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 3, 2012
Renal sympathetic nerve ablation for the treatment of difficult-to-control or refractory hypertension in a haemodialysis patientNicola Di Daniele, Marianna De Francesco, Leano Violo, et al.
Expert Opinion on Therapeutic Targets|April 7, 2020
Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targetsRosamaria Lappano, Damiano Cosimo Rigiracciolo, Antonino Belfiore, et al.
Oncotarget|October 6, 2017
Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs)Ernestina Marianna De Francesco, Gloria Bonuccelli, Marcello Maggiolini, et al.
Expert Opinion on Therapeutic Targets|June 28, 2022
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progressErnestina Marianna De Francesco, Francesca Cirillo, Veronica Vella, et al.
Oncotarget|September 17, 2017
Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapyErnestina Marianna De Francesco, Marcello Maggiolini, Herbert B Tanowitz, et al.
Frontiers in Oncology|November 16, 2020
Mitochondrial Fission Factor (MFF) Inhibits Mitochondrial Metabolism and Reduces Breast Cancer Stem Cell (CSC) ActivityRosa Sánchez-Alvarez, Ernestina Marianna De Francesco, Marco Fiorillo, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 2, 2013
Cross-talk between GPER and growth factor signalingRosamaria Lappano, Paola De Marco, Ernestina Marianna De Francesco, et al.
Cellular Signalling|March 26, 2014
Niacin activates the G protein estrogen receptor (GPER)-mediated signallingMaria Francesca Santolla, Ernestina Marianna De Francesco, Rosamaria Lappano, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|August 24, 2019
Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine)Ernestina Marianna De Francesco, Béla Ózsvári, Federica Sotgia, et al.
Trends in Endocrinology and Metabolism: TEM|June 12, 2022
IFN-I signaling in cancer: the connection with dysregulated Insulin/IGF axisVeronica Vella, Ernestina Marianna De Francesco, Eduardo Bonavita, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 3, 2012
Renal sympathetic nerve ablation for the treatment of difficult-to-control or refractory hypertension in a haemodialysis patientNicola Di Daniele, Marianna De Francesco, Leano Violo, et al.
Expert Opinion on Therapeutic Targets|April 7, 2020
Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targetsRosamaria Lappano, Damiano Cosimo Rigiracciolo, Antonino Belfiore, et al.
Oncotarget|October 6, 2017
Vitamin C and Doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs)Ernestina Marianna De Francesco, Gloria Bonuccelli, Marcello Maggiolini, et al.
Expert Opinion on Therapeutic Targets|June 28, 2022
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progressErnestina Marianna De Francesco, Francesca Cirillo, Veronica Vella, et al.
Oncotarget|September 17, 2017
Targeting hypoxic cancer stem cells (CSCs) with Doxycycline: Implications for optimizing anti-angiogenic therapyErnestina Marianna De Francesco, Marcello Maggiolini, Herbert B Tanowitz, et al.
Frontiers in Oncology|November 16, 2020
Mitochondrial Fission Factor (MFF) Inhibits Mitochondrial Metabolism and Reduces Breast Cancer Stem Cell (CSC) ActivityRosa Sánchez-Alvarez, Ernestina Marianna De Francesco, Marco Fiorillo, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 2, 2013
Cross-talk between GPER and growth factor signalingRosamaria Lappano, Paola De Marco, Ernestina Marianna De Francesco, et al.
Cellular Signalling|March 26, 2014
Niacin activates the G protein estrogen receptor (GPER)-mediated signallingMaria Francesca Santolla, Ernestina Marianna De Francesco, Rosamaria Lappano, et al.
Pageof 7